4573 Biotechnology

Novozymes A/S Period End 31 December 2010

Submitted by YWang on Fri, 2011-06-24 10:55
Novozymes A/S Annual Report 2010
CR Monitor Issue: 
2011/0613
Company covered: 
Novozymes A/S
Period End: 
31 December 2010
Report issued on 24 June 2011 did not identify any changes with significant impacts on the financial statements but covered the following practice issues:
Change
Impairments recorded against know-how intangible assets and empty buildings.
Change
Useful lives of several know-how intangible assets reassessed and reduced.
Change
Improved disclosure of management remuneration.

Genus plc Period End 30 June 2010

Submitted by Company Reporting on Mon, 2010-11-01 10:09
Genus plc Annual Report 2010
Deferred tax asset recognised five years late
UK animal genetics company Genus corrects an error by recognising a deferred tax asset this year that should have been recognised in 2005.

Novozymes A/S Period End 31 December 2009

Submitted by Company Reporting on Tue, 2010-02-09 00:00

41% goodwill not tested “formally” for impairment
Although stating that goodwill has been tested for impairment, Danish biotechnology company Novozymes discloses subsequently that it has not “formally” tested the DKK183 million or 41% of all goodwill allocated to its Enzyme Business, leading to a lack of clarity.